Kalaris Therapeutics Share Price (NASDAQ: KLRS)
$4.05
▲
0.49
(13.76%)
Last updated on
Check the interactive Kalaris Therapeutics Stock chart to analyse performance
Kalaris Therapeutics stock performance
as on August 30, 2025 at 1:29 am IST
- Today's Low:$3.56Today's High:$4.10
12.1%
Downside
Day's Volatility :13.17%
Upside
1.22%
- 52 Weeks Low:$2.1452 Weeks High:$12.90
47.16%
Downside
52 Weeks Volatility :83.41%
Upside
68.6%
Kalaris Therapeutics Stock Returns
Kalaris Therapeutics Inc Key Stats
Check Kalaris Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Kalaris Therapeutics Stock including INR - Dollar returns
The Kalaris Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Kalaris Therapeutics investment value today
Current value as on today
₹28,453
Returns
Returns from Kalaris Therapeutics Stock
Dollar Returns*
₹5,284 (+5.28%)
Indian investors sentiment towards Kalaris Therapeutics Stock
Analyst Recommendation on Kalaris Therapeutics Stock
Kalaris Therapeutics Share Price Target
What analysts predicted
Upside of 406.17%
Target:
$20.50
Current:
$4.05
Kalaris Therapeutics share price target is $20.50, a slight Upside of 406.17% compared to current price of $4.05 as per analysts' prediction.
Kalaris Therapeutics Stock Insights
Price Movement
In the last 7 days, KLRS stock has moved up by 63.3%KLRS vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 147.0%KLRS vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 209.8%
Kalaris Therapeutics Technicals Summary
Sell
Neutral
Buy
Kalaris Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Kalaris Therapeutics Inc Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| 52.99% | -59.06% | -76.54% | -97.62% | -99.43% |
 | 6.48% | -15.2% | -50.31% | -3.3% | -2.01% |
| 1.77% | 24.81% | 62.78% | 79.11% | 29.69% |
 | -14.45% | -19.13% | -17.84% | 34.68% | 41.87% |
 | 13.79% | 83.28% | 75.87% | 111.28% | 242.25% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | NA | -5.25 | 0.0 | 0.0 | NA | 3.42 |
| 14.6 | 14.6 | 1.2 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.73 | -0.05 | -0.01 | NA | 34.32 |
| 27.86 | 27.86 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| NA | $45.3M | -99.43% | NA | 0.0% |
| Buy | $61.4B | -2.01% | 14.6 | 31.37% |
| NA | $36.5B | 29.69% | NA | -3.89% |
| Buy | $100.5B | 41.87% | 27.86 | 31.86% |
| Buy | $59.5B | 242.25% | NA | -12.96% |
About Kalaris Therapeutics Inc
Key Management of Kalaris Therapeutics Inc
Important FAQs about investing in KLRS Stock from India :
What is Kalaris Therapeutics share price today?
Kalaris Therapeutics share price today is $4.05 as on at the close of the market. Kalaris Therapeutics share today touched a day high of $4.10 and a low of $3.56.
What is the 52 week high and 52 week low for Kalaris Therapeutics share?
Kalaris Therapeutics share touched a 52 week high of $12.90 and a 52 week low of $2.14. Kalaris Therapeutics stock price today i.e. is closed at $4.05, lower by 68.6% versus the 52 week high.
How to invest in Kalaris Therapeutics Stock (KLRS) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Kalaris Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Kalaris Therapeutics Shares that will get you 0.3704 shares as per Kalaris Therapeutics share price of $4.05 per share as on August 30, 2025 at 1:29 am IST.
What is the minimum amount required to buy Kalaris Therapeutics Stock (KLRS) from India?
Indian investors can start investing in Kalaris Therapeutics (KLRS) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Kalaris Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025).
Based on Kalaris Therapeutics share’s latest price of $4.05 as on August 30, 2025 at 1:29 am IST, you will get 2.4691 shares of Kalaris Therapeutics. Learn more about
fractional shares .
What are the returns that Kalaris Therapeutics has given to Indian investors in the last 5 years?
Kalaris Therapeutics stock has given -99.43% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
- Webs Defined Volatility Xle
$24.99
-0.04%
- United States 12 Month Natur
$7.81
+1.83%
- F/m U S T Inl-p S (tips) Etf
$50.14
+0.06%
- Pgim Jennison Focused Growth Etf
$105.89
-1.37%
Hitek Global Inc$1.49
+1.36%
Vaneck Vectors Preferred Secs Ex Finls Etf$17.68
-0.73%
Marker Therapeutics Inc$0.93
+3.33%
- Cambria Value And Momentum Etf
$32.55
+0.25%